Skip to main content
. 2015 Sep 14;2015(9):CD006790. doi: 10.1002/14651858.CD006790.pub3

Musch 2005.

Methods Randomised, double‐blind, placebo‐controlled, multicenter trial
Participants 91 adult patients with active UC defined by a Rachmilewitz CAI score of at least 8 points
 Group 1: n=32, M:F = 21:11, median age = 38.0 yrs, median disease duration 7.5 yrs, median Rachmilewitz CAI score = 10, mean endoscopic index score = 10
 Group 2: n=30, M:F = 18:12, median age = 34.5 yrs, median disease duration 6.7 yrs, median Rachmilewitz CAI score = 10, mean endoscopic index score = 9
 Group 3: n=29, M:F = 15:14, median age = 38.0 yrs, median disease duration 3.2 yrs, median Rachmilewitz CAI score = 10, median endoscopic index score = 9
Interventions Group 1: 3 MIU IFN‐β‐1a by SC injection t.i.w
 Group 2: 1 MIU by SC injection IFN‐β‐1a t.i.w
 Group 3: placebo injections
 Duration of treatment 8 weeks
Outcomes Primary outcome was response rate at the end of treatment. Response was defined as reduction of 6 or more CAI points at week 8 compared with baseline
Secondary endpoints: 1. Number of patients with complete response ‐ reduction of CAI to 4 points of less after 8 weeks of treatment; 2. Time until response; 3. Reduction of CAI after 4 and 8 weeks; 4. Reduction of the endoscopic index after 8 weeks; 5. Number of patients receiving colectomy; 6. Reduction of steroid dose
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Low risk Patients were assigned by a centralised randomisation schedule
Blinding (performance bias and detection bias) 
 All outcomes Low risk The study was double‐blind in design
Supervision of the clinical trial was performed by a steering committee of investigators who were blinded from the results throughout the trial
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 4/32 patients in 3 MIU group, 5/30 patients in 1 MIU group, 7/29 patients in placebo group dropped out during treatment
Selective reporting (reporting bias) Low risk All pre‐defined outcomes were reported
Other bias Low risk No other issues were identified